Puma Biotechnology announces results of 2023 annual meeting of stockholders

PUMA BIOTECHNOLOGY, INC.

All eight director nominees elected; highest 'for' vote was Cesano at 30,203,447, lowest was Wilson at 26,825,653.
KPMG LLP ratified as independent auditor for FY2023 with 39,051,453 votes for, 113,960 against.
Advisory say-on-pay proposal approved: 28,584,098 for, 2,112,789 against, 113,566 abstain.
Broker non-votes of 8,447,026 recorded on director election and say-on-pay proposals.
No other proposals or material business conducted at the meeting.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

PUMA BIOTECHNOLOGY, INC. shareholders approved Election of directors at the 2023-06-13 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

Proposal 1: The Company’s stockholders elected the eight nominated directors identified below, each to serve and to hold office for a one-year term until the close of the Company’s next annual meeting of stockholders in 2024 and until their successors have been duly elected and qualified or until their earlier resignation or removal.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

PUMA BIOTECHNOLOGY, INC. shareholders approved Advisory vote to approve the compensation of named executive officers at the 2023-06-13 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

Proposal 3: The Company’s stockholders voted to approve, on an advisory basis, the compensation of the Company’s named executive officers.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

PUMA BIOTECHNOLOGY, INC. shareholders approved Ratification of KPMG LLP as independent registered accounting firm for fiscal year ending December 31, 2023 at the 2023-06-13 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

Proposal 2: The Company’s stockholders ratified the selection of KPMG LLP as the Company’s independent registered accounting firm for the fiscal year ending December 31, 2023.

View on SEC.gov

Browse all shareholder votes →

PUMA BIOTECHNOLOGY, INC. filing history →

Source: SEC EDGAR

accession 0001437749-23-017581

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.